Back to Journals » Clinical Pharmacology: Advances and Applications » Volume 10

The effect of combined treatment with sodium phenylbutyrate and cisplatin, erlotinib, or gefitinib on resistant NSCLC cells

Total article views   Abstract views HTML views PDF downloads Totals
3,018 Dovepress* 2,366 480+ 389 2,846
PubMed Central* 0 172 51 172
Totals 2,366 652 440 3,018
*Since 9 October 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 1 0 1

View citations on PubMed Central and Google Scholar